Special Issue "Immunotherapy for Gastrointestinal Cancer"
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gastrointestinal Oncology".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 19977
Special Issue Editor
Interests: patient care; clinical trials; gastrointestinal tumors; colorectal cancer; gastroesophageal cancer; anal cancer
Special Issue Information
Dear Colleagues,
Gastrointestinal cancers are amongst the most common malignancies worldwide. The past few decades have seen improvements in surgical approaches, tailoring of radiotherapy, and optimized utilization of classic chemotherapy, as well as the introduction of newer targeted therapies. However, for many patients the overall prognosis remains poor. New immunotherapeutic strategies, led by the incorporation of immune-checkpoint inhibitors, are rapidly entering the clinical setting for many GI tumor types, with additional studies and analyses serving to refine their utilization. Multiple additional promising agents and combinations are in development. In this Special Issue, we welcome your contribution to immunotherapy of gastrointestinal cancer.
Dr. Patrick M. Boland
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal cancer
- colorectal cancer
- immunotherapy
- PD-1